Achieve more perspective

Jeroen is co-founder and Chief Scientific Officer of Aiosyn. He is also Professor of Computational Pathology at Radboud University Medical Center in Nijmegen, Netherlands and guest Professor at the Center for Medical Image Science and Visualization in Linköping, Sweden. He studied Computer Science at the Radboud University in Nijmegen. Jeroen currently leads a research group focusing on the use of AI for digitized histopathological tissue sections. His group was among the first to show the potential of AI for analysis of whole slide images. Further research focused on AI improvements to increase robustness and accuracy, and on AI application for diverse tasks, developing models for analysis of breast and colorectal cancer and for renal transplant biopsies. In 2016 and 2017, he coordinated the CAMELYON grand challenges. The CAMELYON data sets are among the largest and most studied in computational Pathology today. Jeroen is member of the board of directors of the Digital Pathology Association, iis leading the ‘AI in Pathology’ taskforce of the European Society of Pathology and is overall coordinator of the Bigpicture project. He is USCAP Nathan Kaufman laureate 2019.

David is co-founder and Chief Technology Officer of Aiosyn. He has a background in computer science and electrical engineering, and a passion for challenges and disruptive technology. He has previous experience building scalable technology for startups as a research engineer. In addition, he holds a PhD in computational pathology with a focus on developing deep learning based algorithms. For the past two years, he has been responsible for the technology that powers Aiosyn’s AI solutions, coordinating efforts between the software engineering and the AI science teams. 

David enjoys spending time at the bouldering gym, and playing tennis and padel outside.

Wouter is co-founder and Chief Operating & Product Officer of Aiosyn. He studied Artificial Intelligence and worked as a software engineer and data scientist. He holds a Ph.D. in computational pathology with a focus on using artificial intelligence for clinical diagnostics. Wouter’s research showed that AI algorithms could grade prostate cancer on the level of experienced pathologists and actively assist pathologists in performing better diagnoses. Wouter was also one of the main organizers of the PANDA challenge, the largest challenge in computational pathology to date, collaborating with Karolinska Institute and Google Health. Wouter’s research was published in top journals like The Lancet Oncology and Nature Medicine.

Wouter enjoys going to the theater in his free time and aspires to be a hobby chef.

Patrick is co-founder and Chief Executive Officer of Aiosyn. He studied Health Sciences and followed a MSc Management and Entrepreneurship in Life Sciences at the VU University. Patrick founded a European life science consulting company specialized in strategy and financing services for medtech and biotech companies (sold in 2018). Early 2020, he co-founded a medical diagnostics company (now part of Microbe&Lab) that provides tests for infectious diseases (e.g., Covid-19) and a platform for at-home testing and health programs for consumers and employers. In 2021, he co-founded Aiosyn in which he will take AI-powered pathology algorithms to patients and doctors. 

Patrick is an enthusiastic amateur cyclist and likes to spend time in the mountains.